21 March 2018
News and Views
Links and Services
The most recent Alimentary Pharmacology & Therapeutics evaluates the safety and tolerability of direct-acting anti-viral agents in the new era of hepatitis C therapy.
Direct-acting anti-virals licensed to treat chronic HCV infection have revolutionised treatment a
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors